You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elotuzumab

Showing 51 - 67 of 67
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Profiling in Multiple Myeloma

Recruiting
  • Multiple Myeloma
    • Torino, TO, Italy
      Aou Citta' Della Salute E Della Scienza Di Torino
    Apr 28, 2021

    Multiple Myeloma Trial in Nagoya-shi, Niigata-shi (BMS-901608 (Elotuzumab) 10 mg, BMS-901608 (Elotuzumab) 20 mg)

    Completed
    Has Results
    • Multiple Myeloma
    • BMS-901608 (Elotuzumab) 10 mg
    • BMS-901608 (Elotuzumab) 20 mg
    • Nagoya-shi, Aichi, Japan
    • +2 more
    Jan 19, 2018

    Hematologic Cancer Trial (elotuzumab, lenalidomide, dexamethasone oral)

    Completed
    Has Results
    • Hematologic Cancer
    • elotuzumab
    • +3 more
    • (no location specified)
    Jan 8, 2018

    Multiple Myeloma Trial in France (Isatuximab, ASCT)

    Recruiting
    • Multiple Myeloma
    • AMIENS Cedex 1, France
    • +67 more
    Mar 28, 2022

    Smoldering Multiple Myeloma Trial in United States (Elotuzumab (BMS-901608; HuLuc63))

    Completed
    Has Results
    • Smoldering Multiple Myeloma
    • Elotuzumab (BMS-901608; HuLuc63)
    • San Diego, California
    • +11 more
    Dec 21, 2017

    Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

    Not yet recruiting
    • Newly Diagnosed Multiple Myeloma
    • Alcalá de Henares, Madrid, Spain
    • +67 more
    Sep 23, 2022

    Multiple Myeloma Trial in Spain (Nivolumab, Pomalidomide, Dexamethasone)

    Terminated
    • Multiple Myeloma
    • Badalona, Spain
    • +11 more
    May 22, 2018

    Multiple Myeloma Trial in Worldwide (Elotuzumab, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Elotuzumab
    • +2 more
    • Corona, California
    • +76 more
    Apr 20, 2018

    Multiple Myeloma Trial in Spain, United States (Elotuzumab, Lirilumab, Urelumab)

    Completed
    • Multiple Myeloma
    • Elotuzumab
    • +2 more
    • Little Rock, Arkansas
    • +6 more
    Oct 30, 2017

    Multiple Myeloma Trial in China (Lenalidomide, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Beijing, China
    • +10 more
    Nov 7, 2019

    Multiple Myeloma Trial in New York (Elotuzumab, Lenalidomide, autologous PBMC reconstitution)

    Completed
    • Multiple Myeloma
    • Elotuzumab
    • +3 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 15, 2017

    Multiple Myeloma Trial in United States (Lenalidomide, Dexamethasone, Elotuzumab (BMS-901608; HuLuc63))

    Completed
    Has Results
    • Multiple Myeloma
    • Atlanta, Georgia
    • +10 more
    Jun 27, 2017

    Relapsed and/or Refractory Multiple Myeloma Trial in Spain (Elotuzumab, Thalidomide, Dexamethasone)

    Completed
    Has Results
    • Relapsed and/or Refractory Multiple Myeloma
    • Elotuzumab
    • +3 more
    • Barcelona, Spain
    • +9 more
    Mar 17, 2017

    Multiple Myeloma Trial (Elotuzumab, Bortezomib, Lenalidomide)

    Withdrawn
    • Multiple Myeloma
    • Elotuzumab
    • +3 more
    • (no location specified)
    Apr 12, 2017

    Multiple Myeloma Trial in New York (Elotuzumab)

    No longer available
    • Multiple Myeloma
    • Elotuzumab
    • New York, New York
      Icahn School.of Medicine at Mount Sinai
    Sep 2, 2015

    Multiple Myeloma Trial in United States (Elotuzumab (HuLuc63))

    Terminated
    • Multiple Myeloma
    • Elotuzumab (HuLuc63)
    • Los Angeles, California
    • +7 more
    Aug 22, 2012

    Multiple Myeloma Trial in United States (HuLuc63)

    Completed
    • Multiple Myeloma
    • Little Rock, Arkansas
    • +7 more
    Sep 21, 2009